Company intelligence / Profile preview

BioProduction Systems

Ownership: Private
Development stage: Commercial

Overview

BioProduction Systems is an active CDMO specializing in the development and scalable manufacturing of recombinant proteins using mammalian (CHO), microbial (E. coli), and other cell systems. They offer process development from early-stage to commercial scale with expertise in analytics, lyophilization, fill-finish drug product work, advanced cell banking, cultivated meat production technologies, probiotics manufacture, and real-time data access for clients. No clinical trial results are reported as they are a service provider.

Therapeutic areas: Other
Modalities: Recombinant proteinProbioticCultivated meat (cell-based food applications)Lyophilized biologics
Industry: Contract Manufacturing Organization

Partnerships

Not publicly listed; likely works with various biotech/pharma clients under confidentiality agreements

Beyond the preview

Go deeper on BioProduction Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioProduction Systems.

Explore the full profile